Y Zhang1. 1. Center for American Indian Health Research, College of Public Health, University of Oklahoma Health Sciences Center, P. O. Box 26901, Oklahoma City, OK 73190, USA. Ying-zhang4@ouhsc.edu
Abstract
AIMS: Cardiovascular disease (CVD) is one of the major public health issues in women among diverse populations across the world. This article reports current information about the occurrence and risk factors of atherosclerotic CVD in American women. DATA SYNTHESIS: The most recent scientific publications from the American Heart Association, the Centers for Disease Control and Prevention, and the National Heart, Lung, and Blood Institute and elsewhere were reviewed with regard to CVD in the US population. We focussed on the atherosclerotic CVD in women, which includes coronary heart disease, stroke and heart failure. Prevalence, incidence and mortality of these diseases in women were described. The statistics about CVD on women were compared to men's. Special physiological changes in women and their relationships to CVD were discussed. The major modifiable risk factors were discussed. CONCLUSION: About 35% women in the United States have some form of CVD and for men, this number is 37.6%. The CVD incidence for women was close to that of men 10 years younger. The gap narrows with advancing age. Since 1984, the number of CVD deaths for women has exceeded those for men. Women represent 52.6% of CVD deaths, and CVD is the leading cause of death in US women. In both men and women risk factors such as hypertension, high blood cholesterol level, smoking, lack of physical activity and obesity increase the probability of developing CVD. Menopause, oral contraceptive use and bilateral oophorectomy in premenopausal women also affect the risk of CVD in women. Copyright 2010 Elsevier B.V. All rights reserved.
AIMS: Cardiovascular disease (CVD) is one of the major public health issues in women among diverse populations across the world. This article reports current information about the occurrence and risk factors of atherosclerotic CVD in American women. DATA SYNTHESIS: The most recent scientific publications from the American Heart Association, the Centers for Disease Control and Prevention, and the National Heart, Lung, and Blood Institute and elsewhere were reviewed with regard to CVD in the US population. We focussed on the atherosclerotic CVD in women, which includes coronary heart disease, stroke and heart failure. Prevalence, incidence and mortality of these diseases in women were described. The statistics about CVD on women were compared to men's. Special physiological changes in women and their relationships to CVD were discussed. The major modifiable risk factors were discussed. CONCLUSION: About 35% women in the United States have some form of CVD and for men, this number is 37.6%. The CVD incidence for women was close to that of men 10 years younger. The gap narrows with advancing age. Since 1984, the number of CVD deaths for women has exceeded those for men. Women represent 52.6% of CVD deaths, and CVD is the leading cause of death in US women. In both men and women risk factors such as hypertension, high blood cholesterol level, smoking, lack of physical activity and obesity increase the probability of developing CVD. Menopause, oral contraceptive use and bilateral oophorectomy in premenopausal women also affect the risk of CVD in women. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: J A Simon; J Hsia; J A Cauley; C Richards; F Harris; J Fong; E Barrett-Connor; S B Hulley Journal: Circulation Date: 2001-02-06 Impact factor: 29.690
Authors: Tobias Kurth; Steven C Moore; J Michael Gaziano; Carlos S Kase; Meir J Stampfer; Klaus Berger; Julie E Buring Journal: Arch Intern Med Date: 2006-07-10
Authors: Elisa T Lee; Thomas K Welty; Linda D Cowan; Wenyu Wang; Dorothy A Rhoades; Richard Devereux; Oscar Go; Richard Fabsitz; Barbara V Howard Journal: Diabetes Care Date: 2002-01 Impact factor: 19.112
Authors: Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger Journal: JAMA Date: 2002-07-03 Impact factor: 56.272
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel Journal: J Womens Health (Larchmt) Date: 2018-12-01 Impact factor: 2.681
Authors: Julie C Weitlauf; Andrea Z LaCroix; Chloe E Bird; Nancy F Woods; Donna L Washington; Jodie G Katon; Michael J LaMonte; Mary K Goldstein; Shari S Bassuk; Gloria E Sarto; Marcia L Stefanick Journal: Womens Health Issues Date: 2015-10-01
Authors: Siegfried Adelhoefer; S M Iftekhar Uddin; Albert D Osei; Olufunmilayo H Obisesan; Michael J Blaha; Omar Dzaye Journal: Radiol Cardiothorac Imaging Date: 2020-12-17
Authors: Ying Zhang; Alicia J Jenkins; Arpita Basu; Julie A Stoner; Maria F Lopes-Virella; Richard L Klein; Timothy J Lyons Journal: J Lipid Res Date: 2015-12-09 Impact factor: 5.922
Authors: Maria E Bleil; Steven E Gregorich; Daniel McConnell; Mitchell P Rosen; Marcelle I Cedars Journal: Menopause Date: 2013-11 Impact factor: 2.953